Trial in Germany looks promising

Posted by askretka @askretka, Aug 25 4:02am

In simple words, we gave a combination of drugs ( pelareorep+ atezolizumab and chemo) to mPDAC patients, which is one of the worst cancers, and 3/3 “safety run-in” patients showed about 50% reduction in their tumor sizes in just 4 months!This is great 🙂

Early days by Oncolytics Biotech and Roche.

Interested in more discussions like this? Go to the Pancreatic Cancer group.

Welcome, @askretka. Do you have pancreatic cancer? Are you looking into clinical trials?

REPLY

Looks like a very small evaluation with just 3 patients. While interesting, I gather it is a very long way from Phase 1/2 clinical trials?

REPLY
@thebobk

Looks like a very small evaluation with just 3 patients. While interesting, I gather it is a very long way from Phase 1/2 clinical trials?

Jump to this post

It's a Phase I/2 Trial. It will now move to 12 patients.

Pelareorep a natural virus has been proven safe in over 1000 patients now.

P3 Breast cancer trial with Pfizer possibly next year. They are hoping to piggyback off that and take to a P3 Pancreatic trial. All depends on next 9 patients I guess.

REPLY
@colleenyoung

Welcome, @askretka. Do you have pancreatic cancer? Are you looking into clinical trials?

Jump to this post

Don't have cancer doing some research for someone else.
The Oncolytics/Roche trial is only a 3 patient safety trial that will now be expanded to 12 patients. Was newest and best I could find. It's very early though.

REPLY
Please sign in or register to post a reply.
  Request Appointment